Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer And GSK Use Novel Funding Mechanism To Send Blockbuster Vaccines To World's Poorest Countries

This article was originally published in The Pink Sheet Daily

Executive Summary

Pfizer and GSK have promised to supply 30 million doses each for the next 10 years. The first 20 percent of the supply will be sold for $7 per dose, while the remaining supply of Pfizer's Prevenar 13 and GSK's Synflorix will be sold for $3.50.
Advertisement

Related Content

ACIP's Support Of FDA-Approved Prevnar 13 Creates Opportunity For Larger Market
ACIP's Support Of FDA-Approved Prevnar 13 Creates Opportunity For Larger Market
GSK Opens First Asian Vaccine Manufacturing Plant In Singapore

Topics

Advertisement
UsernamePublicRestriction

Register

PS070397

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel